Last Updated: June 26, 2026

Suppliers and packagers for izervay


✉ Email this page to a colleague

« Back to Dashboard


izervay

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Astellas IZERVAY avacincaptad pegol sodium SOLUTION;INTRAVITREAL 217225 NDA Astellas Pharma US, Inc. 82829-002-01 1 VIAL, SINGLE-DOSE in 1 CARTON (82829-002-01) / .35 mL in 1 VIAL, SINGLE-DOSE 2023-08-19
Astellas IZERVAY avacincaptad pegol sodium SOLUTION;INTRAVITREAL 217225 NDA Astellas Pharma US, Inc. 82829-002-99 1 VIAL, SINGLE-DOSE in 1 CARTON (82829-002-99) / .35 mL in 1 VIAL, SINGLE-DOSE 2023-08-19
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Last updated: May 25, 2026

ERVAY Suppliers: Which Companies Manufacture, Package, and Supply the Ophthalmic Gene Therapy for Retinal Disease?

IZERVAY is an ophthalmic gene therapy. No complete, source-backed supplier map (manufacturers, fill-finish sites, packaging suppliers, contract manufacturing organizations, or labeled distribution partners) can be produced from the information provided in this request.

What companies manufacture IZERVAY (contract manufacturer and fill-finish)?
No verified manufacturer and fill-finish supply chain data for IZERVAY is available in the provided inputs.

IZERVAY manufacturing sites

No source-backed manufacturing-site list can be produced.

IZERVAY packaging and labeling suppliers

No source-backed packaging and labeling supplier data can be produced.


Who supplies IZERVAY to distributors and pharmacies (US distribution partners)?
No verified distributor or distribution-partner list for IZERVAY is available in the provided inputs.

Authorized distributor network

No source-backed distributor network can be produced.

Hospital vs retail channel suppliers

No source-backed channel split can be produced.


What is the Orange Book status of IZERVAY and does it affect supplier visibility?
No Orange Book entry details for IZERVAY are included in the provided inputs, and IZERVAY’s regulatory listing type cannot be determined from the request.

Reference-listed drug (RLD) mapping

No source-backed RLD mapping can be produced.

Exclusivity and labeling references

No source-backed exclusivity and labeling reference details can be produced.


Which raw-material and vector suppliers support IZERVAY production?
No source-backed vector, plasmid, reagent, or key raw-material supplier list for IZERVAY is available in the provided inputs.

Viral vector and cell substrate supply chain

No source-backed vector supply chain detail can be produced.

Key consumables (filters, bags, single-use systems)

No source-backed consumables supplier detail can be produced.


How do IZERVAY supplier choices affect production capacity and launch scale?
No capacity or scale data tied to specific suppliers is available in the provided inputs.

Manufacturing capacity constraints

No source-backed capacity constraints can be produced.

Supply disruptions and mitigation

No source-backed disruption history can be produced.


Key Takeaways

  • A source-backed supplier list for IZERVAY (manufacturers, fill-finish sites, packaging/labeling suppliers, raw-material vendors, and US distribution partners) cannot be produced from the information provided.

FAQs

  1. Who is the contract manufacturer for IZERVAY?
  2. Where is IZERVAY filled and finished?
  3. Which companies distribute IZERVAY in the US?
  4. What companies supply key biologic or vector inputs for IZERVAY?
  5. How does IZERVAY’s regulatory status (RLD/biologic) change supplier disclosure?

References (APA)
No sources were provided in the request.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.